What is OVARIAN CANCER? Must Watch! | By Cancer Education and Research Institute (CERI)
What is OVARIAN CANCER? | By Cancer Education and Research Institute (CERI)
Ovarian cancer and cervical cancer is often confused with each other. In this episode we explain the differences between ovarian cancer and cervical cancer, ovarian cancer facts, symptoms, diagnosis, stages, and treatment.
Please comment below and let us know your thoughts or questions.
We also recently released our video, in which we explain the newly approved drug, Rubraca (rucaparib), by the FDA for advanced ovarian cancer patients whose tumors have BRCA gene mutation (abnormality). The FDA further approved FoundationFocus CDxBRCA companion diagnostic test for use with Rubraca, which is the first next-generation-sequencing (NGS)-based companion diagnostic approved by the FDA. This test detects the presence of deleterious BRCA gene abnormalities in the tumor tissue of ovarian cancer patients. https://www.youtube.com/watch?v=ojkAqwfmAF0
Read more on our blog on our website: https://www.canceredinstitute.org/cancer-blog-english/-fda-approves-new-treatment-for-advanced-ovarian-cancer
Watch our ovarian cancer series:
Episode #18: Ovarian cancer intro
Episode #19: Ovarian cancer facts
Episode #20: Ovarian cancer symptoms
Episode #21: Ovarian cancer diagnosis
Episode #22: Ovarian cancer stages
Episode #23: Ovarian cancer treatment
Disclaimer: We can not assume responsibility of misinterpretation of content.
Ovarian cancer and cervical cancer is often confused with each other. In this episode we explain the differences between ovarian cancer and cervical cancer, ovarian cancer facts, symptoms, diagnosis, stages, and treatment.
Please comment below and let us know your thoughts or questions.
We also recently released our video, in which we explain the newly approved drug, Rubraca (rucaparib), by the FDA for advanced ovarian cancer patients whose tumors have BRCA gene mutation (abnormality). The FDA further approved FoundationFocus CDxBRCA companion diagnostic test for use with Rubraca, which is the first next-generation-sequencing (NGS)-based companion diagnostic approved by the FDA. This test detects the presence of deleterious BRCA gene abnormalities in the tumor tissue of ovarian cancer patients. https://www.youtube.com/watch?v=ojkAqwfmAF0
Read more on our blog on our website: https://www.canceredinstitute.org/cancer-blog-english/-fda-approves-new-treatment-for-advanced-ovarian-cancer
Watch our ovarian cancer series:
Episode #18: Ovarian cancer intro
Episode #19: Ovarian cancer facts
Episode #20: Ovarian cancer symptoms
Episode #21: Ovarian cancer diagnosis
Episode #22: Ovarian cancer stages
Episode #23: Ovarian cancer treatment
Disclaimer: We can not assume responsibility of misinterpretation of content.
